11.1 Information on toxicological effects
Acute toxicity
Oral: No data available
LC50 Inhalation - Rat - male and female - 4 h - > 0.4 mg/l - vapor (OECD Test Guideline 403)
LD50 Dermal - Rabbit - 20,000 mg/kg
Remarks: (RTECS)
Skin corrosion/irritation
Skin - Rabbit
Result: No skin irritation - 24 h
Remarks: (ECHA)
Serious eye damage/eye irritation
Eyes - Rabbit
Result: No eye irritation - 24 h
Remarks: (ECHA)
Respiratory or skin sensitization
Maximization Test - Guinea pig
Result: negative (OECD Test Guideline 406)
Germ cell mutagenicity
Test Type: Mutagenicity (mammal cell test): chromosome aberration.
Test system: Chinese hamster ovary cells
Metabolic activation: Metabolic activation
Method: OECD Test Guideline 473
Result: positive
Test Type: Ames test
Test system: Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Test Type: unscheduled DNA synthesis assay
Species: Rat
Cell type: Liver cells
Application Route: Oral
Method: OECD Test Guideline 486
Result: negative
Test Type: Micronucleus test
Species: Mouse
Cell type: Bone marrow
Application Route: Intraperitoneal
Method: US-EPA
Result: negative
Remarks: (ECHA)
Carcinogenicity
Suspected of causing cancer.
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Classified based on available data. For more details, see section 2
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Oral - 91 Days - NOAEL (No observed adverse effect level) - 200 mg/kg - LOAEL (Lowest observed adverse effect level) - 400 mg/kg
Repeated dose toxicity - Mouse - male and female - Oral - 90 Days - NOAEL (No observed adverse effect level) - 100 mg/kg
Repeated dose toxicity - Rat - male and female - Dermal - 90 Days - NOAEL (No observed adverse effect level) - 1,000 mg/kg
Repeated dose toxicity - Rat - male and female - inhalation (vapor) - 90 Days - NOAEL (No observed adverse effect level) - 300 mg/kg
Absorption into the body leads to the formation of methemoglobin which in sufficient concentration causes cyanosis. Onset may be delayed 2 to 4 hours or longer., Naphthalene is retinotoxic and systemic absorption of its vapors above 15ppm, may result in:, cataracts, optic neuritis, corneal injury, Eye irritation, Ingestion may provoke the following symptoms:, hemolytic anemia, hemoglobinuria, Nausea, Headache, Vomiting,
Gastrointestinal disturbance, Convulsions, anemia, Kidney injury may occur., Seizures.,
Coma.
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
After absorption:
Headache
Stomach/intestinal disorders
Tremors
Convulsions
Changes in the blood count
Other dangerous properties can not be excluded.
This substance should be handled with particular care.
Heart -